Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1992 Jun;47(6):404–407. doi: 10.1136/thx.47.6.404

Inhaled corticosteroids: benefits and risks.

D M Geddes
PMCID: PMC463800  PMID: 1496495

Full text

PDF
404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali N. J., Capewell S., Ward M. J. Bone turnover during high dose inhaled corticosteroid treatment. Thorax. 1991 Mar;46(3):160–164. doi: 10.1136/thx.46.3.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen M. B., Ray S. G., Leitch A. G., Dhillon B., Cullen B. Steroid aerosols and cataract formation. BMJ. 1989 Aug 12;299(6696):432–433. doi: 10.1136/bmj.299.6696.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baran D. A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma. Br J Dis Chest. 1987 Apr;81(2):170–175. doi: 10.1016/0007-0971(87)90135-5. [DOI] [PubMed] [Google Scholar]
  4. Bisgaard H., Damkjaer Nielsen M., Andersen B., Andersen P., Foged N., Fuglsang G., Høst A., Leth C., Pedersen M., Pelck I. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J Allergy Clin Immunol. 1988 Jun;81(6):1088–1095. doi: 10.1016/0091-6749(88)90874-3. [DOI] [PubMed] [Google Scholar]
  5. Björkander J., Formgren H., Johansson S. A., Millqvist E. Methodological aspects on clinical trials with inhaled corticosteroids: results of two comparisons between two steroid aerosols in patients with asthma. Eur J Respir Dis Suppl. 1982;122:108–117. [PubMed] [Google Scholar]
  6. Boe J., Rosenhall L., Alton M., Carlsson L. G., Carlsson U., Hermansson B. A., Hetta L., Kiviloog J., Karlson B. W., Lundbäck B. Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy. 1989 Jul;44(5):349–355. doi: 10.1111/j.1398-9995.1989.tb00457.x. [DOI] [PubMed] [Google Scholar]
  7. Boe J., Rosenhall L., Alton M., Carlsson L. G., Carlsson U., Hermansson B. A., Hetta L., Kiviloog J., Karlson B. W., Lundbäck B. Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy. 1989 Jul;44(5):349–355. doi: 10.1111/j.1398-9995.1989.tb00457.x. [DOI] [PubMed] [Google Scholar]
  8. Brown P. H., Blundell G., Greening A. P., Crompton G. K. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir Med. 1991 Nov;85(6):501–510. doi: 10.1016/s0954-6111(06)80268-4. [DOI] [PubMed] [Google Scholar]
  9. Brown P. H., Blundell G., Greening A. P., Crompton G. K. Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids. Respir Med. 1991 Nov;85(6):511–516. doi: 10.1016/s0954-6111(06)80269-6. [DOI] [PubMed] [Google Scholar]
  10. Campbell I. A. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax. 1984 Sep;39(9):686–686. doi: 10.1136/thx.39.9.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Capewell S., Reynolds S., Shuttleworth D., Edwards C., Finlay A. Y. Purpura and dermal thinning associated with high dose inhaled corticosteroids. BMJ. 1990 Jun 16;300(6739):1548–1551. doi: 10.1136/bmj.300.6739.1548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Costello J. F., Clark T. J. Response of patients receiving high dose beclomethasone dipropionate. Thorax. 1974 Sep;29(5):571–573. doi: 10.1136/thx.29.5.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ebden P., Jenkins A., Houston G., Davies B. H. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma. Thorax. 1986 Nov;41(11):869–874. doi: 10.1136/thx.41.11.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Field H. V., Jenkinson P. M., Frame M. H., Warner J. O. Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler. Arch Dis Child. 1982 Nov;57(11):864–866. doi: 10.1136/adc.57.11.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fraunfelder F. T., Meyer S. M. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Ophthalmol. 1990 Apr 15;109(4):489–490. doi: 10.1016/s0002-9394(14)74627-6. [DOI] [PubMed] [Google Scholar]
  16. Gaddie J., Petrie G. R., Reid I. W., Skinner C., Sinclair D. J., Palmer K. N. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet. 1973 Aug 11;2(7824):280–281. doi: 10.1016/s0140-6736(73)90788-5. [DOI] [PubMed] [Google Scholar]
  17. Godfrey S., Balfour-Lynn L., Tooley M. A three- to five-year follow-up of the use of the aerosol steroid, beclomethasone dipropionate, in childhood asthma. J Allergy Clin Immunol. 1978 Dec;62(6):335–339. doi: 10.1016/0091-6749(78)90133-1. [DOI] [PubMed] [Google Scholar]
  18. Goldstein E. T., Preskorn S. H. Mania triggered by a steroid nasal spray in a patient with stable bipolar disorder. Am J Psychiatry. 1989 Aug;146(8):1076–1077. doi: 10.1176/ajp.146.8.1076. [DOI] [PubMed] [Google Scholar]
  19. Jennings B. H., Andersson K. E., Johansson S. A. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol. 1991;40(1):77–82. doi: 10.1007/BF00315143. [DOI] [PubMed] [Google Scholar]
  20. Johansson S. A., Andersson K. E., Brattsand R., Gruvstad E., Hedner P. Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Eur J Respir Dis Suppl. 1982;122:74–82. [PubMed] [Google Scholar]
  21. Johansson S. A., Dahl R. A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma. Allergy. 1988 Apr;43(3):173–178. doi: 10.1111/j.1398-9995.1988.tb00415.x. [DOI] [PubMed] [Google Scholar]
  22. Karim A. K., Thompson G. M., Jacob T. J. Steroid aerosols and cataract formation. BMJ. 1989 Oct 7;299(6704):918–918. doi: 10.1136/bmj.299.6704.918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Keelan P., Gray P., Kelly P., Frame M. Comparison of a new corticosteroid aerosol, budesonide, with beclomethasone dipropionate in the treatment of chronic asthma. Ir Med J. 1984 Aug;77(8):244–247. [PubMed] [Google Scholar]
  24. Kewley G. D. Possible association between beclomethasone diproprionate aerosol and cataracts. Aust Paediatr J. 1980 Jun;16(2):117–118. doi: 10.1111/j.1440-1754.1980.tb01276.x. [DOI] [PubMed] [Google Scholar]
  25. Kruszynska Y. T., Greenstone M., Home P. D., Cooke N. J. Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax. 1987 Nov;42(11):881–884. doi: 10.1136/thx.42.11.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Littlewood J. M., Johnson A. W., Edwards P. A., Littlewood A. E. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet. 1988 Jan 16;1(8577):115–116. doi: 10.1016/s0140-6736(88)90310-8. [DOI] [PubMed] [Google Scholar]
  27. Löfdahl C. G., Mellstrand T., Svedmyr N. Glucocorticoids and asthma. Studies of resistance and systemic effects of glucocorticoids. Eur J Respir Dis Suppl. 1984;136:69–79. [PubMed] [Google Scholar]
  28. Milne L. J., Crompton G. K. Beclomethasone dipropionate and oropharyngeal candidiasis. Br Med J. 1974 Sep 28;3(5934):797–798. doi: 10.1136/bmj.3.5934.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nassif E., Weinberger M., Sherman B., Brown K. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. J Allergy Clin Immunol. 1987 Oct;80(4):518–529. doi: 10.1016/0091-6749(87)90002-9. [DOI] [PubMed] [Google Scholar]
  30. Otulana B. A., Varma N., Bullock A., Higenbottam T. High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Respir Med. 1992 Mar;86(2):105–108. doi: 10.1016/s0954-6111(06)80224-6. [DOI] [PubMed] [Google Scholar]
  31. Parker D. R., O'Connor G. T., Sparrow D., Segal M. R., Weiss S. T. The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function. The Normative Aging Study. Am Rev Respir Dis. 1990 Mar;141(3):589–594. doi: 10.1164/ajrccm/141.3.589. [DOI] [PubMed] [Google Scholar]
  32. Pedersen S., Fuglsang G. Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Eur Respir J. 1988 May;1(5):433–435. [PubMed] [Google Scholar]
  33. Peretz A., Bourdoux P. P. Inhaled corticosteroids, bone formation, and osteocalcin. Lancet. 1991 Nov 23;338(8778):1340–1340. doi: 10.1016/0140-6736(91)92648-l. [DOI] [PubMed] [Google Scholar]
  34. Pouw E. M., Prummel M. F., Oosting H., Roos C. M., Endert E. Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ. 1991 Mar 16;302(6777):627–628. doi: 10.1136/bmj.302.6777.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Prahl P., Jensen T., Bjerregaard-Andersen H. Adrenocortical function in children on high-dose steroid aerosol therapy. Results of serum cortisol, ACTH stimulation test and 24 hour urinary free cortical excretion. Allergy. 1987 Oct;42(7):541–544. doi: 10.1111/j.1398-9995.1987.tb00379.x. [DOI] [PubMed] [Google Scholar]
  36. Rafferty P., Tucker L. G., Frame M. H., Fergusson R. J., Biggs B. A., Crompton G. K. Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assessment of relative prednisolone-sparing effects. Br J Dis Chest. 1985 Jul;79(3):244–250. [PubMed] [Google Scholar]
  37. Reid D. M., Nicoll J. J., Smith M. A., Higgins B., Tothill P., Nuki G. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1463–1466. doi: 10.1136/bmj.293.6560.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rosenhall L., Lundqvist G., Adelroth E., Glennow C. Comparison between inhaled and oral corticosteroids in patients with chronic asthma. Eur J Respir Dis Suppl. 1982;122:154–162. [PubMed] [Google Scholar]
  39. Shaw N. J., Edmunds A. T. Inhaled beclomethasone and oral candidiasis. Arch Dis Child. 1986 Aug;61(8):788–790. doi: 10.1136/adc.61.8.788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Smith M. J., Hodson M. E. High-dose beclomethasone inhaler in the treatment of asthma. Lancet. 1983 Feb 5;1(8319):265–269. doi: 10.1016/s0140-6736(83)91686-0. [DOI] [PubMed] [Google Scholar]
  41. Springer C., Avital A., Maayan C., Rosler A., Godfrey S. Comparison of budesonide and beclomethasone dipropionate for treatment of asthma. Arch Dis Child. 1987 Aug;62(8):815–819. doi: 10.1136/adc.62.8.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Stiksa G., Glennow C. Once daily inhalation of budesonide in the treatment of chronic asthma: a clinical comparison. Ann Allergy. 1985 Jul;55(1):49–51. [PubMed] [Google Scholar]
  43. Teelucksingh S., Padfield P. L., Tibi L., Gough K. J., Holt P. R. Inhaled corticosteroids, bone formation, and osteocalcin. Lancet. 1991 Jul 6;338(8758):60–61. doi: 10.1016/0140-6736(91)90058-w. [DOI] [PubMed] [Google Scholar]
  44. Toogood J. H., Baskerville J., Jennings B., Lefcoe N. M., Johansson S. A. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol. 1989 Nov;84(5 Pt 1):688–700. doi: 10.1016/0091-6749(89)90297-2. [DOI] [PubMed] [Google Scholar]
  45. Toogood J. H., Crilly R. G., Jones G., Nadeau J., Wells G. A. Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis. 1988 Jul;138(1):57–61. doi: 10.1164/ajrccm/138.1.57. [DOI] [PubMed] [Google Scholar]
  46. Toogood J. H., Lefcoe N. M., Haines D. S., Jennings B., Errington N., Baksh L., Chuang L. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol. 1977 Apr;59(4):298–308. doi: 10.1016/0091-6749(77)90051-3. [DOI] [PubMed] [Google Scholar]
  47. Varsano I., Volovitz B., Malik H., Amir Y. Safety of 1 year of treatment with budesonide in young children with asthma. J Allergy Clin Immunol. 1990 May;85(5):914–920. doi: 10.1016/0091-6749(90)90077-h. [DOI] [PubMed] [Google Scholar]
  48. Willey R. F., Godden D. J., Carmichael J., Preston P., Frame M., Crompton G. K. Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma. Br J Dis Chest. 1982 Jan;76(1):61–68. [PubMed] [Google Scholar]
  49. Wolff A. H., Adelsberg B., Aloia J., Zitt M. Effect of inhaled corticosteroid on bone density in asthmatic patients: a pilot study. Ann Allergy. 1991 Aug;67(2 Pt 1):117–121. [PubMed] [Google Scholar]
  50. Wolthers O. D., Pedersen S. Growth of asthmatic children during treatment with budesonide: a double blind trial. BMJ. 1991 Jul 20;303(6795):163–165. doi: 10.1136/bmj.303.6795.163. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES